Cost implications & Clinical Prudence in Managing Chronic Coronary Syndromes post ESC-Guidelines
ASEAN Heart Journal · 2020
DOI: 10.31762/ahj2027.0102 ↗Kurz gefasst
Leitlinie in der Zeitschrift ASEAN Heart Journal, 2020. Verfasst von David KL Quek.
Abstract (Originalsprache)
Syndromes post ESC-GuidelinesStable angina or stable coronary artery disease has now been redefined as chronic coronary syndromes (CCS) partly to be more inclusive for several hitherto under-represented, under-recognised non-obstructive coronary artery entities that present as angina-like or myocardial ischemic syndromes.1
Zitieren
APA
Quek, D. K. (2020). Cost implications & Clinical Prudence in Managing Chronic Coronary Syndromes post ESC-Guidelines. ASEAN Heart Journal. https://doi.org/10.31762/ahj2027.0102
Vancouver
Quek DK. Cost implications & Clinical Prudence in Managing Chronic Coronary Syndromes post ESC-Guidelines. ASEAN Heart Journal. 2020. doi:10.31762/ahj2027.0102
BibTeX
@article{Quek2020,
author = {Quek, David KL},
title = {Cost implications & Clinical Prudence in Managing Chronic Coronary Syndromes post ESC-Guidelines},
journal = {ASEAN Heart Journal},
year = {2020},
doi = {10.31762/ahj2027.0102}
}
EUVIMED